Ben Fidler

Senior Reporter, Healthcare, Pharmaceuticals & Biotechnology

As The Deal LLC's senior healthcare reporter, Ben Fidler focuses on M&A transactions and industry trends in the pharmaceutical space. He has written analyses of deals such as Teva Pharmaceutical’s purchase of Cephalon and Takeda Pharmaceutical’s acquisition of Nycomed, among others.

Before switching to the healthcare beat in 2011, Ben had a five-year stint as The Deal's senior bankruptcy reporter, covering restructurings of the Texas Rangers, Delphi, Trump Entertainment Resorts and Blockbuster. In addition, he has written features for The Deal magazine on the bankruptcies of the Phoenix Coyotes and Tropicana Entertainment.